Callan JMB (CJMB) launches $5,000,000 at-the-market common stock offering
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
Callan JMB Inc. entered into an at-the-market Sales Agreement with Alexander Capital, L.P. allowing the company to offer and sell, from time to time, shares of common stock with an aggregate offering price of up to $5,000,000.
Sales will be made as “at the market offerings” under Rule 415, primarily through the Nasdaq Capital Market, and Alexander Capital will act as sales agent on a commercially reasonable efforts basis. Callan JMB will pay a 3.0% commission on gross proceeds, plus capped expense reimbursements, and plans to use net proceeds for working capital and general corporate purposes.
Positive
- None.
Negative
- None.
Insights
Callan JMB sets up a flexible $5,000,000 at-the-market equity program.
Callan JMB Inc. has arranged an at-the-market Sales Agreement with Alexander Capital, enabling periodic issuances of common stock up to $5,000,000. This structure lets the company match equity issuance with market conditions rather than selling all shares at once.
Alexander Capital earns a 3.0% commission on gross proceeds, and its legal costs are reimbursed up to $50,000 initially and $3,000 quarterly. The company plans to direct net proceeds to working capital and general corporate purposes, while also referencing efforts to address Nasdaq’s Stockholders’ Equity Requirement.
The agreement lasts until the full capacity is sold or either party terminates it under specified notice provisions. Actual dilution and capital raised will depend on future sales decisions and market demand, which will be evident only as transactions occur over time.
8-K Event Classification
2 items: 1.01, 9.01
2 items
Item 1.01
Entry into a Material Definitive Agreement
Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Key Figures
ATM capacity: $5,000,000
Sales agent commission: 3.0% of gross proceeds
Initial counsel fee cap: $50,000
+2 more
5 metrics
ATM capacity
$5,000,000
Aggregate offering price of common stock under Sales Agreement
Sales agent commission
3.0% of gross proceeds
Commission to Alexander Capital on each sale
Initial counsel fee cap
$50,000
Maximum reimbursement for Alexander Capital’s counsel at setup
Ongoing quarterly fee cap
$3,000 per quarter
Maximum quarterly reimbursement for Alexander Capital’s counsel
Par value per share
$0.001
Par value of Callan JMB common stock
Key Terms
At-The-Market Issuance Sales Agreement, at the market offerings, Rule 415, emerging growth company, +2 more
6 terms
At-The-Market Issuance Sales Agreement financial
"entered into an At-The-Market Issuance Sales Agreement (the “Sales Agreement”)"
An at-the-market issuance sales agreement lets a company sell newly created shares directly into the public market at the current market price through a broker, on an ongoing basis rather than in one large deal. For investors, it matters because it can provide the company with flexible cash like adding fuel a little at a time, but it can also reduce each existing share’s ownership percentage and put downward pressure on the stock if sales are large.
at the market offerings financial
"sales deemed to be “at the market offerings” as defined in Rule 415"
At-the-market offerings are a way for a company to raise cash by selling newly issued shares directly into the open market at the current trading price through a broker, rather than in a single large sale. Think of it like topping up a gas tank a little at a time at whatever the pump price is; it gives the company flexibility to raise money when conditions are favorable but can increase the number of shares outstanding and dilute existing investors, and frequent or large sales can put downward pressure on the stock price.
Rule 415 regulatory
"“at the market offerings” as defined in Rule 415 promulgated under the Securities Act"
Rule 415 is a U.S. Securities and Exchange Commission regulation that lets a company register securities ahead of time and then offer them for sale in pieces over an extended period under a “shelf” registration, so offerings can be launched quickly when market conditions suit the issuer. For investors, it signals that management has a ready way to raise capital fast—useful for seizing opportunities but potentially dilutive to existing shareholders, like a company pre-loading a credit line it can tap as needed.
emerging growth company regulatory
"Emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
prospectus supplement financial
"including a prospectus supplement dated May 26, 2026 relating to the offering"
A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.
Stockholders’ Equity Requirement regulatory
"plan to regain compliance with the Stockholders’ Equity Requirement within 45 calendar days"
A stockholders’ equity requirement is a minimum amount of net assets — assets minus liabilities — that a company must keep on its balance sheet to meet rules set by regulators, lenders or stock exchanges. Think of it as a required safety buffer or minimum bank balance that shows the company has enough of its own capital to absorb losses; falling below it can limit dividends, trigger covenants or risk sanctions, so investors watch it as a sign of financial health and compliance.
FAQ
What equity program did Callan JMB Inc. (CJMB) establish in this filing?
Callan JMB Inc. established an at-the-market Sales Agreement with Alexander Capital, L.P. allowing sales of common stock up to $5,000,000. Shares may be issued over time directly into the market, giving the company flexibility in how and when it raises additional equity capital.
How much stock can Callan JMB (CJMB) sell under the at-the-market agreement?
The agreement allows Callan JMB to offer and sell common stock with an aggregate offering price of up to $5,000,000. These sales are conducted as at-the-market offerings under Rule 415, primarily through the Nasdaq Capital Market or other existing trading markets for the shares.
What compensation will Alexander Capital receive in Callan JMB’s at-the-market program?
Alexander Capital will receive a commission equal to 3.0% of the gross proceeds from each share sale under the program. Callan JMB also agreed to reimburse specified expenses, including counsel fees up to $50,000 initially and up to $3,000 on a quarterly basis thereafter.
How does Callan JMB intend to use proceeds from the $5,000,000 at-the-market facility?
Callan JMB intends to use net proceeds from stock sales under the Sales Agreement for working capital and general corporate purposes. This gives the company additional financial flexibility, with actual use aligned to operational needs as shares are sold over time in the market.
When does Callan JMB’s at-the-market Sales Agreement with Alexander Capital terminate?
The offering terminates when all shares available under the Sales Agreement are sold or when the agreement is ended as permitted in its terms. Either Callan JMB or Alexander Capital can terminate the arrangement by providing prior written notice to the other party, as specified contractually.
How is Callan JMB’s $5,000,000 at-the-market program registered with the SEC?
Shares sold under the Sales Agreement will be issued pursuant to Callan JMB’s Form S-3 registration statement, File No. 333-296253. A prospectus supplement dated May 26, 2026, specifically covers the offering of up to $5,000,000 of common stock under this at-the-market arrangement.
What Nasdaq compliance issue does Callan JMB reference in this disclosure?
Callan JMB’s forward-looking statements reference its intent to submit a plan to regain compliance with Nasdaq’s Stockholders’ Equity Requirement within 45 calendar days. They also refer to the company’s ability to regain compliance by the deadline imposed by Nasdaq, subject to various disclosed risks and uncertainties.